Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
1 - 10 out of 139Page size: 10
Sort by: Title

  1. A Gene Expression Signature Associated With Overall Survival in Patients With Hepatocellular Carcinoma Suggests a New Treatment Strategy

    Gillet, J., Andersen, Jesper Bøje, Madigan, J. P., Varma, S., Bagni, R. K., Powell, K., Burgan, W. E., Wu, C., Calcagno, A. M., Ambudkar, S. V., Thorgeirsson, S. S. & Gottesman, M., 2016, In: Molecular Pharmacology. 89, 2, p. 263-272 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

    Cancer Genome Atlas Research Network, C. G. A. R. N., 2018, In: Cell Systems. 7, 4, p. 422-437.e1-e7 23 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    A morphogenetic EphB/EphrinB code controls hepatopancreatic duct formation

    Thestrup, M. I., Caviglia, Sara, Cayuso, J., Heyne, R. L. S., Ahmad, R., Hofmeister, W., Satriano, L., Wilkinson, D. G., Andersen, Jesper Bøje & Ober, Elke, 19 Nov 2019, In: Nature Communications. 10, 1, 14 p., 5220.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    A perspective on molecular therapy in cholangiocarcinoma: present status and future directions

    Andersen, Jesper Bøje & Thorgeirsson, S. S., 2014, In: Hepatic Oncology. 1, 1, p. 143-157 15 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. Published

    Acquisition of stem-like features in human cholangiocarcinoma is associated with an oxidative metabolism

    Raggi, C., Navari, N., Taddei, M. L., Sacco, E., Correnti, M., Piombanti, B., Andersen, Jesper Bøje, Ramazzotti, M., Orlandi, I., Chiarugi, P. & Marra, F., 2019, In: Digestive and Liver Disease. 51, e34.

    Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  6. Published

    Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference

    Abou-Alfa, G. K., Andersen, J. B., Chapman, W., Choti, M., Forbes, S. J., Gores, G. J., Hong, T. S., Harding, J. J., Vander Heiden, M. G., Javle, M., Kelley, R. K., Kwong, L. N., Lowery, M., Merrell, A., Miyabe, K., Rhim, A., Saha, S., Sia, D., Tanasanvimon, S., Venook, A. & 7 others, Valle, J. W., Walesky, C., Whetstine, J., Willenbring, H., Zhu, A. X., Mayer, D. & Stanger, B. Z., Dec 2016, In: Journal of Gastrointestinal Oncology. 7, 6, p. 819-827 9 p.

    Research output: Contribution to journal › Conference article › Research › peer-review

  7. Published

    Adverse genomic alterations and stemness features are induced by field cancerization in the microenvironment of hepatocellular carcinomas

    Castven, D., Fischer, M., Becker, D., Heinrich, S., Andersen, Jesper Bøje, Strand, D., Sprinzl, M. F., Strand, S., Czauderna, C., Heilmann-Heimbach, S., Roessler, S., Weinmann, A., Wörns, M. A., Thorgeirsson, S. S., Galle, P. R., Matter, M. S., Lang, H. & Marquardt, J. U., 15 Mar 2017, In: OncoTarget. 8, 30, p. 48688-48700

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Alternative promoters in CpG depleted regions are prevalently associated with epigenetic misregulation of liver cancer transcriptomes

    Nepal, C. & Andersen, Jesper Bøje, 2023, In: Nature Communications. 14, 14 p., 2712.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

    Andersen, Jesper Bøje, Factor, V. M., Marquardt, J. U., Raggi, C., Lee, Y., Seo, D., Conner, E. A. & Thorgeirsson, S. S., 20 Oct 2010, In: Science Translational Medicine. 2, 54, p. 54ra77

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    An integrative approach unveils FOSL1 as an oncogene vulnerability in KRAS-driven lung and pancreatic cancer

    Vallejo, A., Perurena, N., Guruceaga, E., Mazur, P. K., Martinez-Canarias, S., Zandueta, C., Valencia, K., Arricibita, A., Gwinn, D., Sayles, L. C., Chuang, C-H., Guembe, L., Bailey, P., Chang, D. K., Biankin, A., Ponz-Sarvise, M., Andersen, J. B., Khatri, P., Bozec, A., Sweet-Cordero, E. A. & 3 others, Sage, J., Lecanda, F. & Vicent, S., 2017, In: Nature Communications. 8, 14 p., 14294.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 93714085